{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T04:33:05Z","timestamp":1793075585492,"version":"4.5.0"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofliquidbiopsy.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Liquid Biopsy"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.jlb.2026.100500","type":"journal-article","created":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T15:29:33Z","timestamp":1789226973000},"page":"100500","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Using cell free DNA (cfDNA) and RNA (cfRNA) in the diagnosis and monitoring of primary and metastatic CNS tumors"],"prefix":"10.1016","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0050-2030","authenticated-orcid":false,"given":"Maher","family":"Albitar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Charifa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally","family":"Agersborg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Butt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Albitar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na Tosha N.","family":"Gatson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre","family":"Goy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santosh","family":"Kesari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jlb.2026.100500_bib1","doi-asserted-by":"crossref","first-page":"8839","DOI":"10.1038\/ncomms9839","article-title":"Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma","volume":"6","author":"De Mattos-Arruda","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.jlb.2026.100500_bib2","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2016.66.6487","article-title":"Evaluating cancer of the central nervous system through next-generation sequencing of cerebrospinal fluid","author":"Pentsova","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jlb.2026.100500_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmoldx.2021.03.001","article-title":"Clinical experience of cerebrospinal fluid\u2013based liquid biopsy demonstrates superiority of cell-free DNA over cell pellet genomic DNA for molecular profiling","author":"Bale","year":"2021","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.jlb.2026.100500_bib4","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.20040","article-title":"Detection of leptomeningeal disease using cell-free DNA from cerebrospinal fluid","author":"White","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jlb.2026.100500_bib5","series-title":"Unique genetic profiles from cerebrospinal fluid cell-free DNA in leptomeningeal metastases (EGFR-mutant NSCLC)","author":"Li","year":"2018"},{"issue":"12","key":"10.1016\/j.jlb.2026.100500_bib6","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1093\/neuonc\/noz156","article-title":"The potential of cerebrospinal fluid\u2013based liquid biopsy approaches in CNS tumors","volume":"21","author":"Mattox","year":"2019","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.jlb.2026.100500_bib7","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3389\/fcell.2020.00045","article-title":"Beyond the blood: CSF-derived cfDNA for diagnosis and characterization of CNS tumors","volume":"8","author":"McEwen","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.jlb.2026.100500_bib8","series-title":"Cerebrospinal fluid cell-free tumour DNA as a liquid biopsy for primary brain tumours and CNS metastases","author":"Seoane","year":"2019"},{"key":"10.1016\/j.jlb.2026.100500_bib9","doi-asserted-by":"crossref","DOI":"10.1038\/s41416-021-01594-5","article-title":"Cell-free DNA technologies for the analysis of brain cancer","author":"Mair","year":"2022","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jlb.2026.100500_bib10","article-title":"Liquid biopsy in central nervous system metastases","author":"Boire","year":"2019","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.jlb.2026.100500_bib11","article-title":"Circulating tumour DNA from the cerebrospinal fluid allows \u2026 (CSF ctDNA recapitulates tumor genomic alterations)","author":"Escudero","year":"2020","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.jlb.2026.100500_bib12","series-title":"Diagnostic accuracy of cerebrospinal fluid liquid biopsy and MRI for leptomeningeal metastases in solid cancers: a systematic review and meta-analysis","author":"Nakasu","year":"2023"},{"key":"10.1016\/j.jlb.2026.100500_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1079796","article-title":"Comparison of the diagnostic value of liquid biopsy in leptomeningeal metastases: systematic review and meta-analysis","author":"Wang","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.jlb.2026.100500_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlb.2024.100281","article-title":"Liquid biopsy for evaluating mutations and chromosomal aberrations in cerebrospinal fluid from patients with primary or metastatic CNS tumors","author":"Charifa","year":"2024","journal-title":"J Liq Biopsy"},{"key":"10.1016\/j.jlb.2026.100500_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e16261","article-title":"Combining cell-free RNA with cell-free DNA in liquid biopsy for hematologic and solid tumors","volume":"9","author":"Albitar","year":"2023","journal-title":"Heliyon"}],"container-title":["The Journal of Liquid Biopsy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950195426000469?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950195426000469?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T03:59:37Z","timestamp":1793073577000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950195426000469"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":15,"alternative-id":["S2950195426000469"],"URL":"https:\/\/doi.org\/10.1016\/j.jlb.2026.100500","relation":{},"ISSN":["2950-1954"],"issn-type":[{"value":"2950-1954","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Using cell free DNA (cfDNA) and RNA (cfRNA) in the diagnosis and monitoring of primary and metastatic CNS tumors","name":"articletitle","label":"Article Title"},{"value":"The Journal of Liquid Biopsy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jlb.2026.100500","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of The International Society of Liquid Biopsy.","name":"copyright","label":"Copyright"}],"article-number":"100500"}}